ARCHIVES

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

This article is from The Cancer Letter archive.

Vol. 40 No. 32 | August 8, 2014

Download PDF Visit The Full Archive

Related Articles

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005

Budesonide Not Beneficial For Diarrhea In Melanoma

August 28, 2009

Funding opportunities: ASCO breast cancer research award; Lustgarten Foundation prostate cancer research award; NCI program announcements available.

March 5, 2004

Heidelberger Wins $100,000 Award

September 17, 1982

AACI Backs Year 200 Goals, Secures Pledge From NCI that New Centers Won’t Be Added At Expense of Old

July 20, 1984